{"entity":{"edinet_code":"E00970","sec_code":"4548","name_ja":"生化学工業株式会社","name_en":"SEIKAGAKU CORPORATION","industry":"医薬品","industry_en":"Pharmaceutical"},"names_note":"English company names are as filed: each company's own annual report states its English name on the cover page. For a company that files no annual report, EDINET's filer registry is used instead. The as-filed Japanese name is always returned alongside.","filing":{"doc_id":"S100YDGT","filer_name":"生化学工業株式会社","filer_name_en":"SEIKAGAKU CORPORATION","period_end":"2026-03-31","filed_date":"2026-06-18","sha256":"6ab2a9ad25d855f8146f52b475cc889ee7ce0692d419861444894436ed03f034","status":"clean"},"basis":{"measurement":"carrying_amount","entity_scope":"parent_only","share_scope":"listed","trust_included":"unknown","as_of":"2026-03-31","period_type":"annual","labels":{"measurement":"Balance-sheet carrying amount. Under Japanese GAAP listed equities are carried at market with the valuation difference in other comprehensive income, so carrying amount and acquisition cost diverge enormously on positions bought decades ago.","entity_scope":"The reporting company itself (提出会社) — the holding company, excluding the group holders it names separately.","share_scope":"Listed shares only (上場株式).","trust_included":"The filing does not state whether retirement-benefit-trust shares are included. Never guessed — shares contributed to such a trust leave the holder's balance sheet while the settlor normally keeps the right to instruct the vote.","period_type":"From an annual securities report (有価証券報告書). The policy shareholding table appears only in the annual report."},"not_comparable":"Figures are balance-sheet CARRYING AMOUNT at fiscal year end, from the annual securities report. They are NOT comparable with the acquisition-cost or book-value-reduction figures quoted in press coverage and IR presentations, and NOT comparable with interim (half-year) figures, which this product does not hold. Always state the basis with the number, and use check_claim before setting one of our figures against a published one."},"basis_note":"The basis every yen figure on this response is on. entity_scope is read from the filing's own disclosing entities, not assumed: scale_entities and flows each carry their own entity_scope and share_scope, and a figure quoted for one entity is not the group figure.","holdings":[{"holder_table":"reporting","held_name_raw":"科研製薬㈱","held_name_en":"KAKEN PHARMACEUTICAL CO., LTD.","held_sec_code":"4521","match_status":"matched","shares":502500,"book_value_yen":2080000000,"prior_shares":502500,"prior_book_value_yen":2251000000,"purpose_ja":"医薬品事業の販売委託先として関係を強化するため","reciprocal":"有","pct_outstanding":1.3200052642598001,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":2.7623208807553885,"pct_of_holder_assets":2.4089687760585563,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":75299000000,"holder_total_assets_yen":86344000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"参天製薬㈱","held_name_en":"SANTEN PHARMACEUTICAL CO., LTD.","held_sec_code":"4536","match_status":"matched","shares":1130000,"book_value_yen":2017000000,"prior_shares":1130000,"prior_book_value_yen":1602000000,"purpose_ja":"医薬品事業の販売委託先として関係を強化するため","reciprocal":"有","pct_outstanding":0.3512510165530803,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":2.67865443100174,"pct_of_holder_assets":2.3360048179375523,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":75299000000,"holder_total_assets_yen":86344000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"丸全昭和運輸㈱","held_name_en":"Maruzen Showa Unyu Co.,Ltd.","held_sec_code":"9068","match_status":"matched","shares":121400,"book_value_yen":997000000,"prior_shares":121400,"prior_book_value_yen":729000000,"purpose_ja":"当社製品の物流をより円滑化するため","reciprocal":"有","pct_outstanding":0.6192978937137897,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.3240547683236166,"pct_of_holder_assets":1.1546835912165292,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":75299000000,"holder_total_assets_yen":86344000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"みずほリース㈱","held_name_en":"Mizuho Leasing Company, Limited","held_sec_code":"8425","match_status":"matched","shares":665000,"book_value_yen":923000000,"prior_shares":665000,"prior_book_value_yen":693000000,"purpose_ja":"財務面での取引関係を強化するため","reciprocal":"有","pct_outstanding":0.23526598145891797,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.2257798908352036,"pct_of_holder_assets":1.0689798943759845,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":75299000000,"holder_total_assets_yen":86344000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱テクノ菱和","held_name_en":"TECHNO RYOWA LTD.","held_sec_code":"1965","match_status":"matched","shares":49170,"book_value_yen":284000000,"prior_shares":49170,"prior_book_value_yen":129000000,"purpose_ja":"当社の設備調達における取引関係等を円滑にするため","reciprocal":"有","pct_outstanding":0.23775671390725428,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.3771630433339088,"pct_of_holder_assets":0.328916890577226,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":75299000000,"holder_total_assets_yen":86344000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false}],"holders":[{"holder_name":"科研製薬株式会社","holder_name_en":"KAKEN PHARMACEUTICAL CO., LTD.","holder_sec_code":"4521","doc_id":"S100YK2Q","period_end":"2026-03-31","holder_table":"reporting","shares":1207147,"book_value_yen":880000000,"prior_shares":1207147,"prior_book_value_yen":892000000,"purpose_ja":"「第２ 事業の状況　５ 重要な契約等」に記載のとおり、同社製品の国内独占的販売契約を締結しており、医薬品仕入に係る取引円滑化のため、当社の持続成長や企業価値向上から総合的に判断し保有しております。","reciprocal":"有","pct_outstanding":2.210778851550689,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.5961292245578144,"pct_of_holder_assets":0.4937800546524742,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":147619000000,"holder_total_assets_yen":178217000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"みずほリース株式会社","holder_name_en":"Mizuho Leasing Company, Limited","holder_sec_code":"8425","doc_id":"S100YESP","period_end":"2026-03-31","holder_table":"reporting","shares":589968,"book_value_yen":430000000,"prior_shares":589968,"prior_book_value_yen":435000000,"purpose_ja":"発行会社および同社グループ各社との取引関係の維持強化と取引機会の拡大を目的として保有しております。","reciprocal":"有","pct_outstanding":1.0804722022186668,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.09461591439680155,"pct_of_holder_assets":0.010298769704181013,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":454469000000,"holder_total_assets_yen":4175256000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"参天製薬株式会社","holder_name_en":"SANTEN PHARMACEUTICAL CO., LTD.","holder_sec_code":"4536","doc_id":"S100YDH1","period_end":"2026-03-31","holder_table":"reporting","shares":415600,"book_value_yen":303000000,"prior_shares":415600,"prior_book_value_yen":307000000,"purpose_ja":"眼科手術補助剤の売買契約があり、眼科領域における事業関係の強化を図ることを目的に保有しています。（注）","reciprocal":"有","pct_outstanding":0.7611332262802014,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.10202398068615336,"pct_of_holder_assets":0.0716256178595996,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":296989000000,"holder_total_assets_yen":423033000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"丸全昭和運輸株式会社","holder_name_en":"Maruzen Showa Unyu Co.,Ltd.","holder_sec_code":"9068","doc_id":"S100YKCI","period_end":"2026-03-31","holder_table":"reporting","shares":200000,"book_value_yen":145000000,"prior_shares":200000,"prior_book_value_yen":147000000,"purpose_ja":"当社物流事業における取引関係の維持、強化による事業拡大等を目的とし、保有の合理性を総合的に判断し保有しております。","reciprocal":"有","pct_outstanding":0.36628162958623744,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.10043150917389888,"pct_of_holder_assets":0.07087518635286066,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":144377000000,"holder_total_assets_yen":204585000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社テクノ菱和","holder_name_en":"TECHNO RYOWA LTD.","holder_sec_code":"1965","doc_id":"S100YF2U","period_end":"2026-03-31","holder_table":"reporting","shares":57780,"book_value_yen":42000000,"prior_shares":57780,"prior_book_value_yen":42000000,"purpose_ja":"設備工事業の取引先である発行会社との取引関係の維持・強化が当社の企業価値向上に資すると判断し、保有しております。","reciprocal":"有","pct_outstanding":0.10581876278746401,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.06329972419405887,"pct_of_holder_assets":0.041638577150335095,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":66351000000,"holder_total_assets_yen":100868000000,"implausible":false,"reciprocal_held_both_ways":true}],"reclassified":[{"holder_table":"reporting","direction":"to_pure","held_name_raw":"㈱三菱ＵＦＪフィナンシャル・グループ","held_name_en":"Mitsubishi UFJ Financial Group, Inc.","held_sec_code":"8306","match_status":"matched","shares":259700,"book_value_yen":675000000,"fy_of_change_ja":"2026年3月期","reason_ja":"財務面での取引関係を強化するために保有しておりましたが、事業環境や資本効率を踏まえた検証の結果、純投資目的へ変更しております。なお、当該株式については、市場環境や株価動向等を踏まえ、今後の対応を検討いたします。","implausible":false},{"holder_table":"reporting","direction":"to_pure","held_name_raw":"㈱みずほフィナンシャルグループ","held_name_en":"Mizuho Financial Group, Inc.","held_sec_code":"8411","match_status":"matched","shares":24040,"book_value_yen":146000000,"fy_of_change_ja":"2026年3月期","reason_ja":"財務面での取引関係を強化するために保有しておりましたが、事業環境や資本効率を踏まえた検証の結果、純投資目的へ変更しております。なお、当該株式については、市場環境や株価動向等を踏まえ、今後の対応を検討いたします。","implausible":false},{"holder_table":"reporting","direction":"to_pure","held_name_raw":"㈱めぶきフィナンシャルグループ","held_name_en":"Mebuki Financial Group,Inc.","held_sec_code":"7167","match_status":"matched","shares":63180,"book_value_yen":75000000,"fy_of_change_ja":"2026年3月期","reason_ja":"財務面での取引関係を強化するために保有しておりましたが、事業環境や資本効率を踏まえた検証の結果、純投資目的へ変更しております。なお、当該株式については、市場環境や株価動向等を踏まえ、今後の対応を検討いたします。","implausible":false}],"reclassified_note":"As filed, from the annual report's 保有目的を変更した投資株式 table. direction=to_pure means the filer moved the holding from a policy shareholding to 純投資目的 (pure investment); the shares are not necessarily sold, and the position leaves the named policy table in the year of the change. direction=to_policy is the reverse. fy_of_change_ja is the fiscal year the filer states the change took effect, verbatim — some filers list more than one. A filing repeats these rows for several years after the change, so this is a standing disclosure, not a one-year event.","implausible_note":"A row is flagged implausible when its two filed numbers are mutually impossible — book value ÷ shares of ¥1,000,000 or more, which no listed Japanese share reaches. It is a filer tagging error (a value entered at the wrong scale, or a share count in thousands), not an extraction error: the values match the filing's XBRL exactly. Flagged rows are still returned, exactly as filed, but are excluded from the yen aggregates here and counted in excluded_positions / excluded_yen so the exclusion is visible.","notes":[{"holder_table":"reporting","note_no":"1","text_ja":"(注) １．定量的な保有効果については、年間受取配当金及び株式評価損益等を踏まえて収益性、採算性を個別銘柄毎に検証するとともに、事業戦略、事業上の取引関係を総合的に考慮し、保有の合理性を検証しています。"}],"notes_note":"The filing's own numbered footnotes to the named policy table, verbatim. The XBRL numbers them (注)1, (注)2 … and gives no link back to a row, so a note is tied to a position only where it names that issuer.","flows":[{"holder_table":"reporting","share_class":"listed","issues_increased":null,"acquisition_cost_yen":null,"issues_decreased":3,"sale_proceeds_yen":null,"entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","issues_increased":null,"acquisition_cost_yen":null,"issues_decreased":null,"sale_proceeds_yen":null,"entity_scope":"parent_only","share_scope":"unlisted"}],"flows_note":"The filer's own tally, as filed, of how many issues increased or decreased during the year and the yen involved — acquisition cost for increases, sale proceeds for decreases. Read against the reclassification table this separates what was actually sold from what merely changed category. Counts are as filed and are not corrected for filer tagging errors.","no_reduction_measure":"This product holds sale proceeds (売却価額), as filed, for one fiscal year. It does NOT hold a book-value-reduction measure. The two are different measures and must never be presented as equivalent.","scale":{"policy_total_yen":6303000000,"listed_yen":6303000000,"unlisted_yen":null,"listed_issues":5,"unlisted_issues":null,"equity_yen":75299000000,"equity_basis":"jgaap_consolidated","total_assets_yen":86344000000,"assets_basis":"jgaap_consolidated","pct_of_equity":8.370629092019815,"pct_of_assets":7.299870286296674,"equity_basis_label":"Consolidated net assets (Japanese GAAP)","assets_basis_label":"Consolidated net assets (Japanese GAAP)","equity_calc":"total policy shareholdings ÷ shareholders' equity × 100, both as filed in this annual securities report","assets_calc":"total policy shareholdings ÷ total assets × 100, both as filed in this annual securities report"},"scale_entities":[{"holder_table":"reporting","share_class":"listed","book_value_yen":6303000000,"issue_count":5,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"listed"}],"scale_history":[{"year":"2022","period_end":"2022-03-31","policy_total_yen":4431000000,"equity_yen":66340000000,"equity_basis":"jgaap_consolidated","pct_of_equity":6.679228218269521,"pct_of_assets":5.8888416352134385},{"year":"2023","period_end":"2023-03-31","policy_total_yen":4337000000,"equity_yen":67216000000,"equity_basis":"jgaap_consolidated","pct_of_equity":6.452332777910021,"pct_of_assets":5.734876033057851},{"year":"2024","period_end":"2024-03-31","policy_total_yen":5437000000,"equity_yen":72282000000,"equity_basis":"jgaap_consolidated","pct_of_equity":7.5219280042057495,"pct_of_assets":6.647105568800049},{"year":"2025","period_end":"2025-03-31","policy_total_yen":6071000000,"equity_yen":73187000000,"equity_basis":"jgaap_consolidated","pct_of_equity":8.295189036304262,"pct_of_assets":7.2384109118657},{"year":"2026","period_end":"2026-03-31","policy_total_yen":6303000000,"equity_yen":75299000000,"equity_basis":"jgaap_consolidated","pct_of_equity":8.370629092019815,"pct_of_assets":7.299870286296674}],"scale_note":"The policy total is Official (as filed) — the filing's own total carrying amount for the whole policy bucket, listed and unlisted, summed across the entities the filing discloses. It is a floor: holdings at group companies the filing does not name are disclosed nowhere and are not included. The percentages are calculated, not filed, and carry their formula. equity_basis names which figure the denominator is, because filers report under Japanese, IFRS or US accounting standards and an adopter of the latter two stops tagging the Japanese consolidated figure — a parent-only denominator is a different measure and is labelled as one, never silently mixed with a group figure. Percentages are null where equity or total assets is missing or not positive; missing is never shown as zero.","scale_reference":"ISS's Japan proxy voting guidelines recommend a vote against the top executive at a company that allocates 20 percent or more of its net assets to cross-shareholdings, a policy effective from February 2022. ISS counts unilateral holdings, not only mutual ones.","ownership_calc":"shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end","ownership_note":"Derived, not filed. The denominator is the issuer's own reported issued shares less treasury shares, from its annual report nearest this holding's fiscal year end on either side — pct_basis_period_end gives that date, and it can fall after the holding's date where that report is the closer one. For a single-class listed stock this equals the stake's share of market capitalisation. It is null where the issuer files no annual report we hold; where the issuer's share count moves by half or more across the window, because a split or issue makes the share base indeterminate; and where the result would exceed 100%, which is a data fault rather than a stake. It is less exact where the issuer has more than one share class (pct_share_classes > 1), because treasury shares are reported across all classes.","holder_share_calc":"this position's book value ÷ the holder's shareholders' equity (or total assets) × 100, both as filed in the holder's own annual securities report","holder_share_note":"The mirror of pct_outstanding. That sizes a stake against the ISSUER — how much of the issuer this holder owns. pct_of_holder_equity and pct_of_holder_assets size the same position against the HOLDER: how much of its own capital is committed to this one name. Calculated, not filed. Null where the holder's filing gives no usable denominator, never zero. holder_equity_basis says which accounting figure the denominator is, and a parent_only basis is not comparable with a consolidated one. A position CAN legitimately exceed 100% of equity — a holder whose book equity is smaller than one long-held stake is a real and commercially interesting case, not an error — so no ceiling is imposed. Extreme values are worth checking against the filing: where the position's own two filed numbers are mutually impossible the row is marked `implausible`, but that test catches only scale errors visible per share, so it does not catch every bad figure. The book value and share count are returned alongside so the reader can check.","action_calc":"keyword match over the filing's own stated purpose and table footnotes: 株式分割、株式併合、株式交換、株式移転、会社分割、合併、持株会社、商号変更、公開買付、上場廃止","ratio_calc":"current shares ÷ prior shares where that ratio is an exact whole number (or its exact reciprocal) — the signature of a split or a consolidation rather than a trade","history":[{"year":"2019","period_end":"2019-03-31","named_holdings":11,"book_value_yen":5696000000},{"year":"2022","period_end":"2022-03-31","named_holdings":10,"book_value_yen":4426000000},{"year":"2023","period_end":"2023-03-31","named_holdings":10,"book_value_yen":4332000000},{"year":"2024","period_end":"2024-03-31","named_holdings":10,"book_value_yen":5434000000},{"year":"2025","period_end":"2025-03-31","named_holdings":9,"book_value_yen":6068000000},{"year":"2026","period_end":"2026-03-31","named_holdings":5,"book_value_yen":6301000000}],"history_note":"One point per annual report filed. Each year's book value is as filed; book values are fair-valued at period end, so a change reflects both trading and market moves.","provenance":{"trust":"official","note":"Figures exactly as filed in each company's 有価証券報告書 (annual securities report), EDINET. Raw filings archived with SHA-256; doc_id links to the source filing."}}